Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation

Obesity-induced chronic low-grade inflammation originates from adipose tissue and is crucial for obesity-driven metabolic deterioration, including insulin resistance and type 2 diabetes. Chronic inflammation may be a consequence of a failure to actively resolve inflammation and could result from a lack of local specialized proresolving lipid mediators (SPMs), such as resolvins and protectins, which derive from the n-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). We assessed obesity-induced changes of n-3–derived SPMs in adipose tissue and the effects of dietary EPA/DHA thereon. Moreover, we treated obese mice with SPM precursors and investigated the effects on inflammation and metabolic dysregulation. Obesity significantly decreased DHA-derived 17-hydroxydocosahexaenoic acid (17-HDHA, resolvin D1 precursor) and protectin D1 (PD1) levels in murine adipose tissue. Dietary EPA/DHA treatment restored endogenous biosynthesis of n-3–derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving insulin sensitivity. Notably, 17-HDHA treatment reduced adipose tissue expression of inflammatory cytokines, increased adiponectin expression, and improved glucose tolerance parallel to insulin sensitivity in obese mice. These findings indicate that impaired biosynthesis of certain SPM and SPM precursors, including 17-HDHA and PD1, contributes to adipose tissue inflammation in obesity and suggest 17-HDHA as a novel treatment option for obesity-associated complications.

[1]  M. Spite,et al.  Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. , 2012, Annual review of nutrition.

[2]  Hiroki Nakanishi,et al.  Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid* , 2012, The Journal of Biological Chemistry.

[3]  J. Olefsky,et al.  Increased Macrophage Migration Into Adipose Tissue in Obese Mice , 2012, Diabetes.

[4]  V. Arroyo,et al.  Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype , 2011, The Journal of Immunology.

[5]  C. Serhan,et al.  Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes , 2011, Current protocols in immunology.

[6]  R. Schwendener,et al.  Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance , 2011, Diabetes.

[7]  P. Flachs,et al.  Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids , 2011, Diabetologia.

[8]  Yunan Tang,et al.  Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‐diabetic mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  K. Weylandt,et al.  Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α. , 2011, Carcinogenesis.

[10]  Carey N Lumeng,et al.  Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.

[11]  C. Serhan,et al.  Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. , 2011, The Journal of clinical investigation.

[12]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[13]  E. Kriehuber,et al.  Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression , 2010, International Journal of Obesity.

[14]  C. Serhan.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? , 2010, The American journal of pathology.

[15]  T. Randall,et al.  Adaptive immunity and adipose tissue biology. , 2010, Trends in immunology.

[16]  R. Taguchi,et al.  Transgenic Restoration of Long-Chain n-3 Fatty Acids in Insulin Target Tissues Improves Resolution Capacity and Alleviates Obesity-Linked Inflammation and Insulin Resistance in High-Fat–Fed Mice , 2010, Diabetes.

[17]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[18]  G. Smyth,et al.  Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human Obesity , 2010, Diabetes.

[19]  J. Perrard,et al.  CD11c Expression in Adipose Tissue and Blood and Its Role in Diet-Induced Obesity , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[20]  L. Kenner,et al.  Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance , 2010, Diabetes.

[21]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[22]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[23]  V. Arroyo,et al.  Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  T. Stulnig,et al.  Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.

[25]  P. Flachs,et al.  n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet , 2009, Diabetologia.

[26]  A. Saltiel,et al.  Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage Subtypes , 2008, Diabetes.

[27]  J. Olefsky,et al.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. , 2008, Cell Metabolism.

[28]  C. Serhan,et al.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[30]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[31]  C. Glass,et al.  A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways* , 2007, Journal of Biological Chemistry.

[32]  T. Stulnig,et al.  Adipose tissue macrophages. , 2007, Immunology letters.

[33]  Lois E. H. Smith,et al.  Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.

[34]  Charles N. Serhan,et al.  Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.

[35]  W. Waldhäusl,et al.  Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids , 2007, International Journal of Obesity.

[36]  G. Shulman,et al.  n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator–Activated Receptor-α–Dependent Manner , 2007, Diabetes.

[37]  C. Serhan.  Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.

[38]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[39]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[40]  V. Arroyo,et al.  Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  Katherine B Percarpio,et al.  Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.

[42]  K. Weylandt,et al.  Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Waldhäusl,et al.  Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n−3 polyunsaturated fatty acids , 2006, Diabetologia.

[44]  M. Gillum,et al.  Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. , 2006, Diabetes.

[45]  C. Serhan,et al.  The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.

[46]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[47]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[48]  N. Maheshwari,et al.  A Role for the Mouse 12/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense* , 2005, Journal of Biological Chemistry.

[49]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[50]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[51]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[52]  B. Staels,et al.  Peroxisome proliferator-activated receptors in inflammation control. , 2001, The Journal of endocrinology.

[53]  A Mari,et al.  How to measure insulin sensitivity , 1998, Journal of hypertension.